LYRA THERAPEUTICS INC
LYRA
LYRA was delisted on the 16th of March, 2026.
37 hedge funds and large institutions have $138M invested in LYRA THERAPEUTICS INC in 2023 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 4 closing their positions.
49,950% more call options, than puts
Call options by funds: $1M | Put options by funds: $2K
263% more capital invested
Capital invested by funds: $38.1M → $138M (+$100M)
175% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 4
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
19% more funds holding
Funds holding: 31 → 37 (+6)
0.93% more ownership
Funds ownership: 1.19% → 2.12% (+0.93%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$11.1M |
| 2 |
PA
Perceptive Advisors
New York
|
+$10M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$7.89M |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$4.82M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$2.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$1.62M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$139K |
| 3 |
Millennium Management
New York
|
-$120K |
| 4 |
Two Sigma Advisers
New York
|
-$56.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$23.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Simplex Trading
Chicago,
Illinois
| $7K | +$5K | +36 | New |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $5.93K | -$23.6K | -170 | -85% |
|
28
Osaic Holdings
Scottsdale,
Arizona
| $4.8K | +$2.22K | +16 | +160% |
|
|
AWM
29
Ameliora Wealth Management
Zurich,
Switzerland
| $3.08K | – | – | – |
|
|
WAM
30
Worth Asset Management
Dallas,
Texas
| $2.67K | – | – | – |
|
31
Morgan Stanley
New York
| $2.1K | +$1.39K | +10 | New |
|
|
S
32
SignatureFD
Atlanta,
Georgia
| $2.06K | – | – | – |
|
33
US Bancorp
Minneapolis,
Minnesota
| $2.06K | – | – | – |
|
34
RhumbLine Advisers
Boston,
Massachusetts
| $1.22K | +$833 | +6 | New |
|
35
Wells Fargo
San Francisco,
California
| $489 | – | – | – |
|
36
JP Morgan Chase
New York
| $140 | – | – | – |
|
37
UBS Group
Zurich,
Switzerland
| $74 | -$2.36K | -17 | Closed |
|
38
Fidelity Investments
Boston,
Massachusetts
| $45 | – | – | – |
|
|
39
Millennium Management
New York
| – | -$120K | -1,162 | Closed |
|
|
40
Two Sigma Advisers
New York
| – | -$56.9K | -566 | Closed |
|
41
Squarepoint
New York
| – | -$23.4K | -226 | Closed |
|
42
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$139 | +1 | New |
|
LYRA Hedge Fund Activity: Q2 2023 in Review
37 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q2 2023, worth a combined $138M — up 263% from $38.1M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new LYRA positions and 4 closed out — a net gain of 6 holders — while 11 added to existing stakes and 4 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $11.1M. The largest seller was Pura Vida Investments, cutting an estimated $1.62M.
- 37 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q2 2023, up from 31 in Q1 2023.
- Funds reported $138M of LYRA THERAPEUTICS INC stock for Q2 2023, up 263% quarter-over-quarter.
- 10 funds opened new LYRA THERAPEUTICS INC positions in Q2 2023 and 4 closed out, a net change of +6 holders.
- The largest LYRA THERAPEUTICS INC buyer in Q2 2023 was Armistice Capital, an estimated $11.1M added.
- The largest LYRA THERAPEUTICS INC seller in Q2 2023 was Pura Vida Investments, an estimated $1.62M sold.
Based on aggregated 13F filings for Q2 2023.